The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
The endothelin axis: emerging role in cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metastasis to bone: causes, consequences and therapeutic opportunities
Mundy, G. R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc867 · Cited by 2,777
Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors
Daub, H., Ulrich Weiss, F., Wallasch, C., & Ullrich, A. (1996) · Nature · doi:10.1038/379557a0 · Cited by 1,476
Levin, E. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508103330607 · Cited by 711
Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate
Nelson, J. B., Hedican, S. P., George, D. J., Reddi, A. H., Piantadosi, S., Eisenberger, M. A., & Simons, J. W. (1995) · Nature Medicine · doi:10.1038/nm0995-944 · Cited by 622
Self-citationLüscher, T. F., & Barton, M. (2000) · Circulation · doi:10.1161/01.cir.102.19.2434 · Cited by 596
Krum, H., Viskoper, R. J., Lacourciere, Y., Budde, M., & Charlon, V. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803193381202 · Cited by 570
Carducci, M. A., Padley, R. J., Breul, J., Vogelzang, N. J., Zonnenberg, B. A., Daliani, D. D., Schulman, C. C., Nabulsi, A. A., Humerickhouse, R. A., Weinberg, M. A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.176 · Cited by 371
Self-citationSalani, D., Taraboletti, G., Rosanò, L., Di Castro, V., Borsotti, P., Giavazzi, R., & Bagnato, A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64807-9 · Cited by 341
Self-citationGrowth regulatory properties of endothelins
Battistini, B., Chailler, P., D'Orléans-Juste, P., Brière, N., & Sirois, P. (1993) · Peptides · doi:10.1016/0196-9781(93)90057-n · Cited by 334
Self-citationEndothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer.
Nelson, J. B., Chan‐Tack, K. M., Hedican, S. P., Magnuson, S. R., Opgenorth, T. J., Bova, G. S., & Simons, J. W. (1996) · PubMed · Cited by 333
Self-citationMolecular mechanisms of osteolytic bone metastases
Guise, T. A. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12+<2892::aid-cncr2>3.0.co;2-y · Cited by 331
Papandreou, C. N., Usmani, B., Geng, Y., Bogenrieder, T., Freeman, R., Wilk, S., Finstad, C. L., Reuter, V. E., Powell, C. T., Scheinberg, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-050 · Cited by 277
Organization of the Gene Encoding the Human Endothelin-converting Enzyme (ECE-1)
Valdenaire, O., Rohrbacher, E., & Mattei, M.-G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.29794 · Cited by 210
Bagnato, A., Salani, D., Castro, V. D., et al. (1999) · PubMed · Cited by 207
Self-citationSpinella, F., Rosanò, L., Di Castro, V., Natali, P. G., & Bagnato, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202421200 · Cited by 199
Self-citationRole of Endothelin-1 in Neovascularization of Ovarian Carcinoma
Salani, D., Di Castro, V., Nicotra, M. R., Rosanò, L., Tecce, R., Venuti, A., Natali, P. G., & Bagnato, A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64791-8 · Cited by 189
Self-citationStructural Organization and Chromosomal Assignment of the Gene Encoding Endothelin
Bloch, K. D., Friedrich, S. P., Lee, M. E., Eddy, R. L., Shows, T. B., & Quertermous, T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81698-2 · Cited by 177
Endothelin-1 as an Autocrine/Paracrine Apoptosis Survival Factor for Endothelial Cells
Shichiri, M., Kato, H., Marumo, F., & Hirata, Y. (1997) · Hypertension · doi:10.1161/01.hyp.30.5.1198 · Cited by 176
Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells.
Rosanò, L., Varmi, M., Salani, D., Castro, V. D., Spinella, F., Natali, P. G., & Bagnato, A. (2001) · PubMed · Cited by 161
Self-citationNew therapeutics that antagonize endothelin: promises and frustrations
Remuzzi, G., Perico, N., & Benigni, A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd962 · Cited by 160
Carducci, M. A., Nelson, J. B., Kathy Bowling, M., Rogers, T., Eisenberger, M. A., Sinibaldi, V., Donehower, R., Leahy, T. L., Carr, R. A., Isaacson, J. D., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.028 · Cited by 159
Self-citationLahav, R., Heffner, G. C., & Patterson, P. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11496 · Cited by 150
Nelson, J. B., Lee, W. H., Nguyen, S. H., Jarrard, D. F., Brooks, J. D., Magnuson, S. R., Opgenorth, T. J., Nelson, W. G., & Bova, G. S. (1997) · PubMed · Cited by 143
Self-citationFactors regulating the growth of metastatic cancer in bone.
Boyce, B. F., Yoneda, T., & Guise, T. A. (1999) · Endocrine Related Cancer · doi:10.1677/erc.0.0060333 · Cited by 143
Bufalo, D. D., Castro, V. D., Biroccio, A., Varmi, M., Salani, D., Rosanò, L., Trisciuoglio, D., Spinella, F., & Bagnato, A. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.3.524 · Cited by 142
Self-citationEndothelium-derived factors as paracrine mediators of prostate cancer progression
Pirtskhalaishvili, G., & Nelson, J. B. (2000) · The Prostate · Cited by 142
Self-citationVacca, F., Bagnato, A., Catt, K. J., et al. (2000) · PubMed · Cited by 127
Self-citationAsham, E., Shankar, A. I., Loizidou, M., Fredericks, S., Miller, K., Boulos, P. B., Burnstock, G., & Taylor, I. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2193 · Cited by 116
Expression of the endothelin-B receptor in pigment cell lesions of the skin
Demunter, A., Wolf‐Peeters, C. D., Degreef, H. J., et al. (2001) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280000362 · Cited by 113
Endothelin attenuates apoptosis in human smooth muscle cells
Wu-Wong, J. R., CHIOU, J. W., DICKINSON, R., & OPGENORTH, J. T. (1997) · Biochemical Journal · doi:10.1042/bj3280733 · Cited by 109
Autocrine actions of endothelin-1 as a growth factor in human ovarian carcinoma cells.
Bagnato, A., Tecce, R., Moretti, C., Castro, V. D., Spergel, D. J., & Catt, K. J. (1995) · PubMed · Cited by 103
Self-citationAhmed, S. I., Thompson, J., Coulson, J. M., & Woll, P. J. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.4.3795 · Cited by 99
Endothelin Receptor Antagonism
Opgenorth, T. J. (1995) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60665-1 · Cited by 86
Modulation of Human Colon Tumor-Stromal Interactions by the Endothelin System
Egidy, G., Juillerat‐Jeanneret, L., Jeannin, J., Korth, P., Bosman, F. T., & Pinet, F. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64825-0 · Cited by 78
Growth inhibition of cervix carcinoma cells in vivo by endothelin A receptor blockade.
Bagnato, A., Cirilli, A., Salani, D., Simeone, P., Muller, A., Nicotra, M. R., Natali, P. G., & Venuti, A. (2002) · PubMed · Cited by 78
Self-citationAugmented expression of endothelin‐1, endothelin‐3 and the endothelin‐B receptor in breast carcinoma
Alanen, Deng, & Chakrabarti, S. K. (2000) · Histopathology · doi:10.1046/j.1365-2559.2000.00795.x · Cited by 75
Endothelin-2 is a hypoxia-induced autocrine survival factor for breast tumor cells.
Grimshaw, M. J., Naylor, S., & Balkwill, F. R. (2002) · PubMed · Cited by 74
Pagotto, U., Arzberger, T., Hopfner, Ú., Sauer, J., Renner, U., NEWTON, C. J., Lange, M., Uhl, E., Weindl, A., & Stalla, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118249 · Cited by 73
Regulation of apoptosis by vasoactive peptides
Filippatos, G. S., Gangopadhyay, N. N., Lalude, O. O., Parameswaran, N., Said, S. I., Spielman, W. S., & Uhal, B. D. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.4.l749 · Cited by 71
ENDOTHELINS IN HEALTH AND DISEASE: AN OVERVIEW
Goldie, R. G. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03014.x · Cited by 63
Harland, S. P., Kuc, R. E., Pickard, J. D., & Davenport, A. P. (1998) · Neurosurgery · doi:10.1097/00006123-199810000-00097 · Cited by 59
Venuti, A., Salani, D., Manni, V., Poggiali, F., & Bagnato, A. (2000) · The FASEB Journal · doi:10.1096/fj.00-0024com · Cited by 57
Self-citationEberle, J., Weitmann, S., Thieck, O., Pech, H., Orfanos, C. E., & Paul, M. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00598.x · Cited by 55
Endothelin Receptor Antagonists: Current Status and Perspectives
Clozel, M. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200000002-00015 · Cited by 26
ABT-627, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma growth in vitro
Salani, D., Rosanò, L., Castro, V. D., Spinella, F., Venuti, A., Padley, R. J., Nicotra, M. R., Natali, P. G., & Bagnato, A. (2002) · Clinical Science · doi:10.1042/cs103s318s · Cited by 22
Self-citation
Cited by
Deciphering and Reversing Tumor Immune Suppression
Motz, G. T., & Coukos, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.005 · Cited by 598
Buckanovich, R. J., Facciabene, A., Kim, S., Benencia, F., Sasaroli, D., Balint, K., Katsaros, D., O'Brien-Jenkins, A., Gimotty, P. A., & Coukos, G. (2008) · Nature Medicine · doi:10.1038/nm1699 · Cited by 546
Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases
Guise, T. A., Mohammad, K. S., Clines, G., Stebbins, E. G., Wong, D. H., Higgins, L. S., Vessella, R., Corey, E., Padalecki, S., Suva, L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1007 · Cited by 539
Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
Gide, T. N., Wilmott, J. S., Scolyer, R. A., & Long, G. V. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2267 · Cited by 454
Cancer pain and its impact on diagnosis, survival and quality of life
Mantyh, P. W. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1914 · Cited by 441
Metadata
- Authors
- Nelson, J., Bagnato, A., Battistini, B., & Nisen, P.
- Venue
- Nature Reviews Cancer
- Published
- 2003-02
- Volume
- 3
- Issue
- 2
- Pages
- 110-116
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1986266121
- Cited by
- 564
- References
- 45
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.